4 and and 5= 0
4 and and 5= 0.021) at 24 h and 7.9-fold (= 0.014) at 48 h in response to LMB-100 (Fig.?5= 0.28) and 48 h (4.27-fold = 0.014) (Fig. LMB-100, was designed. LMB-100 consists of a humanized Fab that targets human mesothelin (hMSLN) and a B-cell epitope silenced, 24 kD fragment of PE (PE24) (10). PE-based…
